Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Features
Are labels on commercial products, which can be seen worldwide, synonymous to the pages of print publications, which can linger in public sight for days or years?
Features
The Court of Appeals of Ohio, Eighth District, affirmed an order to compel the production of documents from trademark lawyers for John Malm, former manager of musician Trent Reznor, for use in litigation between Malm and his counsel from an earlier suit that Reznor had filed against Malm.
Features
When the cash-strapped recording industry announced at the end of 2008 that it would largely drop its aggressive litigation campaign against unauthorized file sharers, some observers saw this as a defeat for record labels. But numerous court rulings have been issued over the past few years that debate and/or establish legal guidelines that will be referenced in file-sharer cases that are either still in the pipeline or may later crop up. This article examines some of the most recent of these cases and decisions.
President Barack Obama executed The American Recovery and Reinvestment Act of 2009 (the "Stimulus Act") on Feb. 17, 2009. The new legislation, while aimed at stimulating the economy and increasing patient safety, has another side that health law attorneys need to be aware of.
An examination of the reasons why health care providers fail to meet their ethical obligation to disclose errors can shed light on how mandatory error reporting will change malpractice litigation.
One of the newer ideas for reducing medical errors is to have medical providers use electronic medical record keeping methods. However, the single greatest inhibitor to taking advantage of technology is the requirement for an initial investment and, in the medical records technology area, this could be significant.
Features
A spate of billion- and hundred-million-dollar settlements with the Department of Justice (DOJ) illustrates how the investigation of off-label promotions of drugs and devices has emerged as a predominant theory in pharmaceutical and medical-device prosecutions.
